Back

Genetic status and response patterns to mavacamten: an echocardiographic signature of reverse remodeling from 3 portuguese centers

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Left ventricular hypertrophy: from hypertrophic cardiomyopathy to cardiac amyloidosis Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ines Miranda

Hospital Professor Doutor Fernando Fonseca, Amadora (Portugal)

5 More presentations in this session

Presentation thumbnail
Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort
Doctor M. Desai (Cleveland, US)
Abstract
Presentation thumbnail
Musculoskeletal events and risk of amyloidosis in the general population
Professor A. Tybjaerg-Hansen (Copenhagen, DK)
Abstract
Presentation thumbnail
Circulating transthyretin as an independent systemic vulnerability signal in transthyretin amyloidosis: insights from the French HEAR Registry
Assistant Professor A. Zaroui (Creteil, FR)
Abstract
Presentation thumbnail
Changes over time in AI-based echocardiographic metrics before and after therapy in ATTR cardiomyopathy
Ms A. Walser (Zurich, CH)
Abstract
Presentation thumbnail
LA cardiomyopathy in ATTR-CM: the incremental prognostic value of LA strain
Doctor M. Sobral Domingues (Lisbon, PT)
Abstract

Access the full session

Session thumbnail
Left ventricular hypertrophy: from hypertrophic cardiomyopathy to cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Comprehensive cardiovascular magnetic resonance for evaluating structural myocardial changes in patients with hypertrophic obstructive cardiomyopathy treated with the first myosin inhibitor
1 September 2025
thumbnail
Congress Presentation
Phenotypic predictors of pathogenic variants in probands with hypertrophic cardiomyopathy
28 August 2022
thumbnail
Congress Presentation
Cardiac reverse remodeling in real life, a therapeuthic objective.
22 May 2023
thumbnail
Congress Presentation
Electrocardiographic markers of left ventricular hypertrophy indicate response to mavacamten in hypertrophic obstructive cardiomyopathy
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources